OVID THERAPEUTICS
Ovid is a pure play neurology company focused on rare and orphan diseases of the brain. They were founded in 2014 to leverage recent advances in science and medicine to find optimal therapies. They seek to identify and develop late stage, de-risked medicines with significant potential. Their rationale for developing these medicines is based on key insights from their scientific founders and confirmed in discussions with leading experts in the field. Their products are protected by strong intellectual property. They apply the most efficient processes to bring safe and effective therapies to patients. They are based in New York City but have collaborators and are working with patients across the United States and the globe.
OVID THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care
Founded:
2014-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.ovidrx.com
Total Employee:
11+
Status:
Active
Contact:
(212) 776-4381
Email Addresses:
[email protected]
Total Funding:
134.12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Mobile Non Scaleable Content
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Imara
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Stock Details
Investors List
Sphera Funds Management
Sphera Funds Management investment in Series B - Ovid Therapeutics
Jennison Associates
Jennison Associates investment in Series B - Ovid Therapeutics
Redmile Group
Redmile Group investment in Series B - Ovid Therapeutics
Tekla Capital Management
Tekla Capital Management investment in Series B - Ovid Therapeutics
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - Ovid Therapeutics
DoubleLine Equity Healthcare Fund
DoubleLine Equity Healthcare Fund investment in Series B - Ovid Therapeutics
Sanofi Ventures
Sanofi Ventures investment in Series B - Ovid Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Ovid Therapeutics
Official Site Inspections
http://www.ovidrx.com Semrush global rank: 50.69 K Semrush visits lastest month: 2.39 M
- Host name: 230.95.196.35.bc.googleusercontent.com
- IP address: 35.196.95.230
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Ovid Therapeutics"
Our Company - Ovid Therapeutics
Search for: Our Company. Our Company. Our Story; Leadership; Board of Directors; Scientific Advisory BoardSee details»
Our Story - Ovid Therapeutics
Our mission Ovid seeks to deliver medicines that create new possibilities and more good days for people with epilepsies and brain conditions. Our team is curious and persevering in our mission to serve patient communities. We …See details»
Ovid Therapeutics Reports Business Updates and Second Quarter …
Aug 13, 2024 This approach included restructuring the organization and initiating ongoing …See details»
Ovid Therapeutics - Crunchbase Company Profile & Funding
Ovid is a pure play neurology company focused on rare and orphan diseases of the brain. They …See details»
Ovid Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
The poster presented at the Epilepsy Pipeline Conference can be found under the Posters and …See details»
Ovid Therapeutics Inc. - Ovid Therapeutics Strengthens Board ...
Jul 8, 2021 Further information about the leadership team of Ovid Therapeutics can be found …See details»
Ovid Therapeutics Inc. - Ovid Therapeutics Reports Business …
Mar 15, 2022 Ovid executing on its strategy to build a leading epilepsy pipeline OV329 …See details»
Patient Resources - Ovid Therapeutics - ovidrx.com
While funds may be limited at this time, Ovid is committed to the communities we serve. We are keen to explore options to provide volunteers or other resources to support your organization. For more information on how Ovid can help, please …See details»
Ovid Therapeutics - Overview, News & Similar companies
View Ovid Therapeutics (www.ovidrx.com) location in New York, United States , revenue, …See details»
Ovid Therapeutics Company Profile | Management and Employees …
[email protected]: Ovid Therapeutics Top Competitors. Company Employees Revenue Top …See details»
Ovid Therapeutics - Company Profile - Tracxn
Aug 17, 2021 Ovid Therapeutics - Developer of therapeutics for rare neurological diseases. …See details»
Leadership - Ovid Therapeutics
Our leadership & governance Our management team collectively has decades of experience …See details»
Working At Ovid Therapeutics: Company Overview and Culture
Mar 14, 2024 ovidrx.com. Organization Type. Public. CEO. Jeremy Max Levin. Social Media. …See details»
Investor Relations - Ovid Therapeutics Inc.
Nov 12, 2024 Ovid Therapeutics is a New York-based biopharmaceutical company dedicated …See details»
Ovid Therapeutics, Inc. (Ovid Therapeutics, Inc.) - 药物管线_专利_ …
The poster presented at the Epilepsy Pipeline Conference can be found under the Posters and …See details»
Contact Us - Ovid Therapeutics
Our Corporate Headquarters Hudson Commons 441 9th Avenue New York, NY 10001 (646) …See details»
Ovid Therapeutics Reports Business Updates and Third Quarter …
Sep 30, 2024 A Phase 1 SAD/MAD study of OV329 is progressing as planned, and based on …See details»
Our Pipeline - Ovid Therapeutics
We are cultivating a differentiated pipeline of small molecule medicines that utilize first-in-class …See details»
Ovid Therapeutics Inc. - News
Aug 8, 2024 [email protected]. Quick Links. SEC Filings; Investor Email Alerts. To opt …See details»